Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aayush Wellness Ltd, an integrated healthcare company, informed the stock exchanges about a board meeting held on July 1, 2025, where the board approved the launch of its new 'Aayush Health' teleconsultation and patient management platform. The platform, available at www.aayush.health and as a mobile app, will let patients consult verified doctors 24x7, access digital prescriptions, manage health records, and schedule appointments, with a special focus on Tier 2 and Tier 3 cities where healthcare access is limited. The company is targeting the USD 1.62 billion Indian telemedicine and healthcare records management market, which is growing at a CAGR of 21.2%. The platform supports ABHA ID creation, aligning with government initiatives like the Ayushman Bharat Digital Mission (ABDM), National Digital Health Mission (NDHM), and the Unified Health Interface (UHI).
This is a new business vertical entry for the company into a high-growth segment, which could open up fresh revenue streams. For shareholders, the move signals management's push toward digital healthcare expansion, though execution and adoption will be key to actual revenue impact on the stock.